CD31 signaling promotes the detachment at the uropod of extravasating neutrophils allowing their migration to sites of inflammation

  1. Francesco Andreata
  2. Marc Clément
  3. Robert A Benson
  4. Juliette Hadchouel
  5. Emanuele Procopio
  6. Guillaume Even
  7. Julie Vorbe
  8. Samira Benadda
  9. Véronique Ollivier
  10. Benoit Ho-Tin-Noe
  11. Marie Le Borgne
  12. Pasquale Maffia
  13. Antonino Nicoletti
  14. Giuseppina Caligiuri  Is a corresponding author
  1. Laboratory for Vascular Translational Science, France
  2. University of Glasgow, United Kingdom
  3. Université Paris Cité, INSERM, France
  4. Université de Paris, INSERM U1149, CNRS ERL8252, France

Abstract

Effective neutrophil migration to sites of inflammation is crucial for host immunity. A coordinated cascade of steps allows intravascular leukocytes to counteract the shear stress, transmigrate through the endothelial layer and move towards the extravascular, static environment. Those events are tightly orchestrated by integrins but, while the molecular mechanisms leading to their activation have been characterized, the regulatory pathways promoting their detachment remain elusive. In light of this, it has long been known that Platelet-Endothelial Cell Adhesion Molecule (Pecam1, also known as CD31) deficiency blocks leukocyte transmigration at the level of the outer vessel wall, yet the associated cellular defects are controversial. In this study, we combined an unbiased proteomic study with in vitro and in vivo single-cell tracking in mice to study the dynamics and role of CD31 during neutrophil migration. We found that CD31 localizes to the uropod of migrating neutrophils along with closed β2-integrin and is required for essential neutrophil actin/integrin polarization. Accordingly, the uropod of Pecam1-/- neutrophils is unable to detach from the extracellular matrix, while antagonizing integrin binding to extracellular matrix components rescues this in vivo migratory defect. Conversely, we showed that sustaining CD31 co-signaling actively favors uropod detachment and effective migration of extravasated neutrophils to sites of inflammation in vivo. Altogether, our results suggest that CD31 acts as a molecular rheostat controlling integrin-mediated adhesion at the uropod of egressed neutrophils thereby triggering their detachment from the outer vessel wall to reach the inflammatory sites.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for Figures 1-5.

Article and author information

Author details

  1. Francesco Andreata

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
  2. Marc Clément

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6479-8360
  3. Robert A Benson

    Institute of Infection, Immunology and Inflammation, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    No competing interests declared.
  4. Juliette Hadchouel

    INSERM UMR_S1155, Université Paris Cité, INSERM, Paris, France
    Competing interests
    No competing interests declared.
  5. Emanuele Procopio

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
  6. Guillaume Even

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
  7. Julie Vorbe

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
  8. Samira Benadda

    Centre de recherche sur l'inflammation, Université de Paris, INSERM U1149, CNRS ERL8252, Paris, France
    Competing interests
    No competing interests declared.
  9. Véronique Ollivier

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
  10. Benoit Ho-Tin-Noe

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
  11. Marie Le Borgne

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3439-4867
  12. Pasquale Maffia

    Institute of infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3926-4225
  13. Antonino Nicoletti

    Laboratory for Vascular Translational Science, Paris, France
    Competing interests
    Antonino Nicoletti, is an inventorn patents filed (Improved CD31 peptides" PCT/EP2013/062806) related to the work presented in this manuscript. No other potential conflicts of interest relevant to this article exist.".
  14. Giuseppina Caligiuri

    Laboratory for Vascular Translational Science, Paris, France
    For correspondence
    giuseppina.caligiuri@inserm.fr
    Competing interests
    Giuseppina Caligiuri, is an inventor on patents filed (Improved CD31 peptides" PCT/EP2013/062806) related to the work presented in this manuscript. No other potential conflicts of interest relevant to this article exist.".
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4973-2205

Funding

MSDAVENIR (SAVE-Brain)

  • Antonino Nicoletti

Agence Nationale de la Recherche (10-LABX-0017 Inflamex"")

  • Marc Clément

Agence Nationale de la Recherche (DS0404-16-RHUS-00010 iVASC"")

  • Giuseppina Caligiuri

Engineering and Physical Sciences Research Council (grant EP/L014165/1)

  • Pasquale Maffia

British Heart Foundation (PG/19/84/34771)

  • Pasquale Maffia

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All the investigations were conformed to the directive 2010/63/EU of the European Parliament and formal approval was granted by the local Animal Ethics Committee (Comité d'étique Bichat-Debré, Paris, France).

Copyright

© 2023, Andreata et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,197
    views
  • 135
    downloads
  • 7
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Francesco Andreata
  2. Marc Clément
  3. Robert A Benson
  4. Juliette Hadchouel
  5. Emanuele Procopio
  6. Guillaume Even
  7. Julie Vorbe
  8. Samira Benadda
  9. Véronique Ollivier
  10. Benoit Ho-Tin-Noe
  11. Marie Le Borgne
  12. Pasquale Maffia
  13. Antonino Nicoletti
  14. Giuseppina Caligiuri
(2023)
CD31 signaling promotes the detachment at the uropod of extravasating neutrophils allowing their migration to sites of inflammation
eLife 12:e84752.
https://doi.org/10.7554/eLife.84752

Share this article

https://doi.org/10.7554/eLife.84752

Further reading

    1. Cell Biology
    2. Immunology and Inflammation
    Alejandro Rosell, Agata Adelajda Krygowska ... Esther Castellano Sanchez
    Research Article

    Macrophages are crucial in the body’s inflammatory response, with tightly regulated functions for optimal immune system performance. Our study reveals that the RAS–p110α signalling pathway, known for its involvement in various biological processes and tumourigenesis, regulates two vital aspects of the inflammatory response in macrophages: the initial monocyte movement and later-stage lysosomal function. Disrupting this pathway, either in a mouse model or through drug intervention, hampers the inflammatory response, leading to delayed resolution and the development of more severe acute inflammatory reactions in live models. This discovery uncovers a previously unknown role of the p110α isoform in immune regulation within macrophages, offering insight into the complex mechanisms governing their function during inflammation and opening new avenues for modulating inflammatory responses.

    1. Cell Biology
    Affiong Ika Oqua, Kin Chao ... Alejandra Tomas
    Research Article

    G protein-coupled receptors (GPCRs) are integral membrane proteins which closely interact with their plasma membrane lipid microenvironment. Cholesterol is a lipid enriched at the plasma membrane with pivotal roles in the control of membrane fluidity and maintenance of membrane microarchitecture, directly impacting on GPCR stability, dynamics, and function. Cholesterol extraction from pancreatic beta cells has previously been shown to disrupt the internalisation, clustering, and cAMP responses of the glucagon-like peptide-1 receptor (GLP-1R), a class B1 GPCR with key roles in the control of blood glucose levels via the potentiation of insulin secretion in beta cells and weight reduction via the modulation of brain appetite control centres. Here, we unveil the detrimental effect of a high cholesterol diet on GLP-1R-dependent glucoregulation in vivo, and the improvement in GLP-1R function that a reduction in cholesterol synthesis using simvastatin exerts in pancreatic islets. We next identify and map sites of cholesterol high occupancy and residence time on active vs inactive GLP-1Rs using coarse-grained molecular dynamics (cgMD) simulations, followed by a screen of key residues selected from these sites and detailed analyses of the effects of mutating one of these, Val229, to alanine on GLP-1R-cholesterol interactions, plasma membrane behaviours, clustering, trafficking and signalling in INS-1 832/3 rat pancreatic beta cells and primary mouse islets, unveiling an improved insulin secretion profile for the V229A mutant receptor. This study (1) highlights the role of cholesterol in regulating GLP-1R responses in vivo; (2) provides a detailed map of GLP-1R - cholesterol binding sites in model membranes; (3) validates their functional relevance in beta cells; and (4) highlights their potential as locations for the rational design of novel allosteric modulators with the capacity to fine-tune GLP-1R responses.